Over 64% of NPCs are deficient in a pathway that depends on the breast cancer susceptibility genes BRCA1 and BRCA2 [11], which accurately repair DNA crosslinks and breaks via the homologous recombination pathway. This evidence concerns the gene BRCA2 and breast carcinoma.